Treatment of myasthenia gravis based on the theory of "hidden pathogen"
RAN Weizheng1 YUE Xifeng2 GAO Fang3 LI Nannan3 LIU Jialin4 ZHANG Xinning1 WANG Yao1 CHEN Zhigang3
1.Beijing University of Chinese Medicine, Beijing 100029, China;
2.TCM Department, Shenzhen Longhua District Central Hospital, Guangdong Province, Shenzhen 518110, China;
3.NO.1 Neurology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China;
4.NO.3 Neurology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
Abstract：Myasthenia gravis (MG) is a kind of acquired autoimmune disease with neuromuscular junction transmission disorder, which is always characterized by insidious onset. It is progressive or develops alternately with remission and recurrence, and can be induced or aggravated by infection, fatigue and other factors. Combined with the discussion of related symptoms of MG in the ancient literature and the modern researches, it is believed that hidden pathogen plays an important role in the pathogenesis of MG. Therefore, in the treatment of MG, on the basis of supplementing deficiency, attention should be paid to the differentiation and treatment of hidden pathogen. In the acute stage, reinforcing deficiency shouled be paid equal attention with eliminating pathogenic factors. In the remission stage, gradually reduce eliminating pathogenic factors while increase efforts to reinforcing deficiency. Reinforcing deficiency mainly benefits spleen and kidney, while eliminating pathogens is given different treatment methods according different factors: pathogenic toxin, heat, dampness, phlegm and blood stasis.
冉维正1 岳喜峰2 高芳3 李楠楠3 刘佳霖4 张新宁1 王垚1 陈志刚3. 从“伏邪”角度论治重症肌无力[J]. 中国医药导报, 2019, 16(12): 145-149.
RAN Weizheng1 YUE Xifeng2 GAO Fang3 LI Nannan3 LIU Jialin4 ZHANG Xinning1 WANG Yao1 CHEN Zhigang3. Treatment of myasthenia gravis based on the theory of "hidden pathogen". 中国医药导报, 2019, 16(12): 145-149.
2019, Vol. 16 
京公网安备 11010502046598号